Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations

Miscellaneous

Miscellaneous
I
Kennedy, Laura
NCT06253871
VICCPHI24527

A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor.

Multiple Cancer Types

Germ Cell (Pediatrics), Pediatrics
II
Esbenshade, Adam
NCT04684368
COGACNS2021



An Open-Label, Multicenter Study of LY4050784, a Selective SMARCA2/BRM Inhibitor, in Advanced Solid Tumor Malignancies with SMARCA4/BRG1 Alterations

Miscellaneous

Miscellaneous
I
Davis, Elizabeth
NCT06561685
VICC-DTPHI24160



Phase I/II Study of Silmitasertib (CX-4945) in Combination with Chemotherapy in Children and Young Adults with Relapsed Refractory Solid Tumors

Not Available
I/II
Not Available
NCT06541262
VICCPED24526

A Phase 3, Multicenter, Randomized, Open-Label Study of Etentamig Compared with Standard Available Therapies in Subjects with Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)

Multiple Myeloma

Multiple Myeloma
III
Baljevic, Muhamed
NCT06158841
VICC-DTPCL23493

A Randomized Trial of Neratinib, a PAN-ERBB Inhibitor, Alone or in Combination with Palbociclib, a CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial

Multiple Cancer Types

Bladder, Cervical, Colon, Esophageal, GIST, Gastric/Gastroesophageal, Gastrointestinal, Head/Neck, Liver, Lung, Non Small Cell, Ovarian, Rectal, Urologic, Uterine
II
Choe, Jennifer
NCT06126276
ECOGMDEAY191-N5

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.